180 Life Sciences (ATNFW) Stock Price, News & Analysis

Company Overview

180 Life Sciences Ltd. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics in the fields of immuno-oncology and rare musculoskeletal diseases. The company’s pipeline is organized into two primary portfolios: one targeting solid tumor malignancies through innovative immunomodulatory approaches, and another addressing chronic pain and cartilage degeneration in conditions such as osteoarthritis.

In its rare disease and rheumatology portfolio, 180 Life Sciences is advancing an investigational nerve growth factor (NGF) inhibitor that has shown preclinical evidence of pain reduction and cartilage repair in osteoarthritis models. The immuno-oncology arm centers on next-generation antagonists of specific seven-transmembrane receptors, designed to recruit and activate macrophages for targeted tumor cell destruction in solid tumors.

Headquartered in New York City, 180 Life Sciences maintains research operations in both the United States and the United Kingdom and collaborates with academic institutions and contract research organizations to drive its programs through preclinical and clinical stages. The company was founded in 2018 and has since built a platform to support multiple therapeutic candidates.

Under the leadership of Chief Executive Officer Dr. Daniel Cohen, 180 Life Sciences is progressing several assets toward mid- and late-stage clinical trials, with the goal of delivering first-in-class or best-in-class treatments that address significant unmet medical needs in oncology and musculoskeletal health.

Key Stats

• Today's Range: $0.0070 to $0.0101
• 50-Day Range: $0.0069 to $0.0102
• 52-Week Range: $0.00 to $0.04
• Volume: 199,946 shs
• Average Volume: 104,089 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ATNFW Stock Analysis - Frequently Asked Questions

How have ATNFW shares performed this year?

180 Life Sciences' stock was trading at $0.0094 on January 1st, 2025. Since then, ATNFW stock has increased by 1.1% and is now trading at $0.0095.

How do I buy shares of 180 Life Sciences?

Shares of ATNFW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ATNFW
• CIK: 1690080
• Web: 180lifesciences.com
• Phone: 650-507-0669
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A